TABLE 2.
CLINICAL CHARACTERISTICS BY IRAK-1 HAPLOTYPE
| IRAK-1 Haplotype | Variant | Heterozygous | Wild Type |
|---|---|---|---|
| N (%) | 21 (14) | 12 (8) | 122 (78) |
| Age, yr (mean ± SD) | 53 ± 14.7 | 45 ± 20 | 52.5 ± 16.5 |
| Male, % | 80.0 | 0.0 | 60.0 |
| Cancer, % | 19.0 | 0.0 | 22.4 |
| End-stage liver failure, % | 14.3 | 18.0 | 10.4 |
| Chronic obstructive pulmonary disease, % | 9.5 | 9.0 | 8.0 |
| Alcohol abuse, % | 19.0 | 18.0 | 15.2 |
| Diabetes, % | 19.0 | 27.0 | 16.0 |
| Immunosuppression, % | 23.8 | 27.0 | 23.2 |
| Congestive heart failure, % | 4.8 | 0.0 | 8.8 |
| HIV, % | 0.0 | 0.0 | 0.0 |